Transcranial bionic far-infrared field effect therapeutic apparatus, method, device and storage medium

Abstract

The present invention discloses a transcranial bionic far-infrared field effect therapeutic apparatus, method, equipment and storage medium, the technical solution of which includes: an inductive transceiver, a coupled resonant circuit and a processor suitable for implementing a computer program; the computer program is loaded by the processor and executes the following steps: receiving a target signal transmitted by the inductive transceiver, wherein the target current is a target signal converted from a target electromagnetic wave received by the inductive transceiver; calling a preset algorithm according to the target signal to calculate and obtain a target wavelength range, and outputting a corresponding frequency coded signal to the coupled resonant circuit according to the target wavelength range, wherein the frequency coded signal passes through the coupled resonant circuit and emits an infrared resonant wave of the target wavelength range through the inductive transceiver. The present invention realizes active regulation of changes in cell membrane potential, so that sodium and potassium ions move in an orderly manner, and effectively strengthens cell metabolism and activity.

Description

Technical Field

[0001] The present invention belongs to the field of infrared therapeutic apparatus, and in particular relates to a transcranial bionic far-infrared field effect therapeutic apparatus, method, equipment and storage medium. Background Art

[0002] Ischemic cerebrovascular disease refers to a disorder of blood supply to the brain based on lesions of blood vessels, vascular walls or hemodynamic disorders supplying the brain, which leads to necrosis or softening of brain tissue in the corresponding blood supply area due to ischemia and hypoxia, and causes short-term or persistent local or diffuse brain damage, resulting in a series of syndromes of neurological impairment. Ischemic cerebrovascular disease is one of the three major diseases that cause human death, second only to heart disease and cancer, and is characterized by high morbidity, high disability rate and high mortality rate. In order to treat and prevent ischemic cerebrovascular disease, the existing technical solutions are mainly divided into a variety of treatment options such as drug treatment and surgical treatment. The advantages of drug treatment, such as antiplatelet drugs and anticoagulants, are to help reduce blood viscosity and reduce the risk of thrombosis, but the disadvantage is that it may cause bleeding and requires regular monitoring. For example, the advantage of blood pressure drugs is to effectively lower blood pressure and reduce vascular damage, but the disadvantage is that there may be side effects, such as dizziness and fatigue. The advantage of surgical treatment, such as intravascular angioplasty, is that it can effectively remove blockages and restore blood flow, but the disadvantage is that there are surgical risks and complications.

[0003] In non-drug therapy, far-infrared therapy technology is a new technology with great development potential. It has the advantages of wide indications, good efficacy, quick results, low cost, simple method, no damage, no pain, and small side effects. It has developed rapidly in my country. Objects in nature always absorb energy radiated by other objects, and objects with a temperature higher than absolute zero (-273℃) will radiate part of the energy at a certain wavelength, commonly known as thermal radiation. When an object absorbs energy, electron vibration will occur, causing the electron to jump to a higher energy level and leave the original orbit. In the process from high energy level to low energy level, energy will be released, which is called radiation energy. The radiation energy is output in the form of infrared rays. Therefore, all objects above absolute zero emit infrared rays to varying degrees. Far infrared rays are a kind of electromagnetic wave, a radiation with strong thermal effect. Its wavelength that is beneficial to the human body is 4 to 14μm. Sunbathing is this band range in sunlight. People also call the far infrared rays of 4 to 14μm "the line of life." Far infrared rays have strong penetration and radiation power, significant temperature control effect and resonance effect, and are easily absorbed by objects and converted into internal energy of objects. After being absorbed by the human body, far infrared rays not only produce thermal effects on the surface of the skin, but also cause vibration of water molecules in the body. Through resonance absorption, the far infrared light energy that penetrates the human skin is converted into thermal energy, promoting the temperature rise of deep subcutaneous tissue. This effect can stimulate cell activity, cause capillary expansion, accelerate blood flow, increase microcirculation blood flow, strengthen metabolism between tissues, increase tissue regeneration capacity, improve the body's immune capacity, and play a series of medical and health care effects.

[0004] At present, the commonly used materials and products that generate far infrared rays include: biochar, carbon fiber products, tourmaline, far infrared ceramics and products, (non) metal oxides and silicon carbide, graphene, etc. In the prior art, the commonly used materials and products that generate far infrared rays are applied to products in different fields to generate far infrared rays. The traditional far infrared thermal effect increases the movement frequency of potassium and sodium ions, but it does not necessarily pass faster. There may also be congestion, which is easy to cause secondary problems. Since the source of chronic diseases is tissue dysfunction and slow metabolism, the reason for tissue dysfunction is cell dysfunction, and cell dysfunction is due to the disordered movement of potassium and sodium ions in cells, how to change the disordered movement of potassium and sodium ions from disorder to order is crucial for the treatment of chronic diseases. Summary of the invention

[0005] The purpose of the present invention is to provide a transcranial bionic far-infrared field effect therapeutic apparatus, method, device and storage medium to achieve active regulation of changes in cell membrane potential, so that sodium and potassium ions move in an orderly manner, and effectively enhance cell metabolism and activity.

[0006] The first aspect of the present invention provides a transcranial bionic far-infrared field effect therapeutic apparatus, comprising: an inductive transceiver, a coupled resonant circuit and a processor suitable for implementing a computer program; the inductive transceiver is connected to the processor, the processor is connected to the coupled resonant circuit, and the coupled resonant circuit is connected to the inductive transceiver;

[0007] The computer program is loaded by the processor and executes the following steps:

[0008] Receiving a target signal transmitted by the inductive transceiver, wherein the target current is a target signal converted from a target electromagnetic wave received by the inductive transceiver;

[0009] A preset algorithm is called according to the target signal to calculate the target wavelength range, and a corresponding frequency coded signal is output to the coupled resonant circuit according to the target wavelength range, wherein the frequency coded signal, after passing through the coupled resonant circuit, emits an infrared resonance wave in the target wavelength range through an inductive transceiver.

[0010] Optionally, the step of calculating a target wavelength range by invoking a preset algorithm according to the target signal includes:

[0011] After receiving the target signal, calling the preset algorithm, wherein the preset algorithm includes:

[0012] Substitute the preset normal human body temperature into Wien's displacement law to obtain the target wavelength.

[0013] Optionally, the target wavelength range is 9.322 μm to 9.358 μm.

[0014] Optionally, the step of calculating a target wavelength range by invoking a preset algorithm according to the target signal includes:

[0015] After receiving the target signal, calling the preset algorithm, wherein the preset algorithm includes:

[0016] After receiving the selected human body part instruction, determining the corresponding part temperature according to the human body part instruction;

[0017] Substituting the temperature of the part into Wien's displacement law to obtain the target wavelength;

[0018] The target wavelength is added to the preset wavelength to obtain the maximum wavelength, and the target wavelength is subtracted from the preset wavelength to obtain the minimum wavelength, thereby obtaining the target wavelength range.

[0019] Optionally, outputting a corresponding frequency coded signal to the coupled resonance circuit according to the target wavelength range includes:

[0020] Selecting a first frequency, a second frequency and a third frequency from the target wavelength range, wherein the electromagnetic wave corresponding to the first frequency is an electromagnetic wave that causes hyperpolarization of the cell membrane potential, the electromagnetic wave corresponding to the second frequency is an electromagnetic wave that causes depolarization of the cell membrane potential, and the electromagnetic wave corresponding to the third frequency is an electromagnetic wave that causes repolarization of the cell membrane potential;

[0021] A corresponding frequency coded signal is output to the coupled resonant circuit according to a preset frequency sequence, wherein the preset frequency sequence is a preset transmission sequence of a first frequency, a second frequency, and a third frequency.

[0022] Optionally, the preset frequency sequence is to cyclically emit electromagnetic waves in the order of a first frequency, a second frequency and a third frequency.

[0023] Optionally, the preset frequency sequence is to cyclically emit electromagnetic waves in the order of a first frequency, a third frequency and a second frequency.

[0024] The second aspect of the present invention provides a bionic far-infrared field effect treatment method, comprising: being applied to a transcranial bionic far-infrared field effect treatment device, the device comprising an inductive transceiver, a coupled resonant circuit and a processor suitable for implementing a computer program; the method comprises the following steps:

[0025] Receiving a target signal transmitted by the inductive transceiver, wherein the target current is a target signal converted from a target electromagnetic wave received by the inductive transceiver;

[0026] A preset algorithm is called according to the target signal to calculate the target wavelength range, and an oscillation signal of the target frequency is output to the coupled resonant circuit according to the target wavelength range, wherein the oscillation signal, after passing through the coupled resonant circuit, emits an infrared resonance wave of the target wavelength range through an inductive transceiver.

[0027] A third aspect of the present invention provides a computer device, comprising a memory and a processor, wherein the memory stores a computer program, and wherein the processor implements the steps of the above method when executing the computer program.

[0028] A fourth aspect of the present invention provides a computer-readable storage medium having a computer program stored thereon, wherein the computer program implements the steps of the above method when executed by a processor.

[0029] The technical solution provided by the present invention has the following advantages and effects: after the processor receives the target signal, the preset algorithm is called to calculate the target wavelength range, that is, the wavelength range of the infrared resonance wave emitted by the transceiver antenna to the human body is determined to treat the human body. After the target wavelength range is determined, the corresponding frequency coding signal is determined according to the target wavelength range, and the corresponding frequency coding signal is output to the coupled resonant circuit, so that the coupled resonant circuit emits the infrared resonance wave of the target wavelength range through the induction transceiver antenna, and emits the infrared resonance wave according to the frequency coding signal, so as to realize the active regulation of the change of cell membrane potential, so that the sodium and potassium ions move in an orderly manner, and effectively enhance the cell metabolism and activity. BRIEF DESCRIPTION OF THE DRAWINGS

[0030] Figure 1 is a circuit connection diagram of a resonance chip provided by an embodiment of the present invention;

[0031] Figure 2 is a flowchart of a computer program provided by an embodiment of the present invention;

[0032] Figure 3 is a schematic diagram of the potential change of the cell membrane provided by an embodiment of the present invention;

[0033] Figure 4 is an exploded schematic diagram of a treatment head provided by an embodiment of the present invention;

[0034] Figure 5 It is a schematic diagram of the overall structure of the transcranial bionic far-infrared field effect therapeutic device provided by an embodiment of the present invention;

[0035] Figure 6 is an exploded schematic diagram of a clamping arm provided by an embodiment of the present invention;

[0036] Figure 7 is an exploded schematic diagram of a head-mounted body provided by an embodiment of the present invention;

[0037] Figure 8 It is a diagram of the internal structure of a computer device provided by an embodiment of the invention.

[0038] Description of reference numerals:

[0039] 1. Head-mounted body; 11. Front shell; 111. First opening; 12. Back shell; 13. Silicone pad; 14. Pressure ring; 15. Button; 16. Circuit board; 2. Clamping arm; 21. Connecting rod; 211. Card slot; 22. Front cover; 23. Back cover; 221. Card block; 3. Treatment head; 31. Shell; 311. Upper shell, 312; Lower shell; 313. Modification ring; 32. Brushless motor; 33. Rotating tray; 34. Rotating plate; 35. Resonance chip; 351. Inductive transceiver; 352. Coupled resonance circuit; 353. Processor; 36. Nano-optical component; 361. Ring plate; 362. Nano-lamp beads; 4. Silicone sleeve; 5. Front clamping ring; 6. Rear clamping ring; 7. Battery. DETAILED DESCRIPTION

[0040] In order to facilitate the understanding of the present invention, specific embodiments of the present invention will be described in more detail below with reference to the accompanying drawings.

[0041] Unless otherwise specified or defined, the "first, second..." used in this article is merely used to distinguish names and does not represent a specific quantity or order.

[0042] Unless specifically stated or defined otherwise, the term "and / or" as used herein includes any and all combinations of one or more of the associated listed items.

[0043] It should be noted that, in this document, “fixed to” or “connected to” may mean directly fixing or connecting to an element, or indirectly fixing or connecting to an element.

[0044] like Figure 1 As shown, the present invention provides a transcranial bionic far-infrared field effect therapeutic device, including: an inductive transceiver 351, a coupling resonance circuit 352 and a processor 353 suitable for implementing a computer program; the inductive transceiver 351 is connected to the processor 353, the processor 353 is connected to the coupling resonance circuit 352, and the coupling resonance circuit 352 is connected to the inductive transceiver 351.

[0045] In actual applications, the inductive transceiver 351 is a transceiver antenna, which is used to receive electromagnetic waves emitted by the human body and the environment, and use the electromagnetic waves emitted by the human body and the environment as target electromagnetic waves. After receiving the target electromagnetic waves, the transceiver antenna converts the target electromagnetic waves into target signals and transmits them to the processor 353. The processor 353 can be a chip such as MCU or single-chip microcomputer. The processor 353 loads the computer program and then executes it to obtain a calculation result, and transmits the calculation result to the coupling resonance circuit 352. The coupling resonance circuit 352 transmits infrared resonance waves to the human body through the transceiver antenna.

[0046] The computer program is loaded by the processor 353 and executes the following steps:

[0047] Step S1 , receiving a target signal transmitted by the inductive transceiver 351 , wherein the target current is a target signal converted from a target electromagnetic wave received by the inductive transceiver 351 .

[0048] Specifically, after the transceiver antenna receives the electromagnetic waves emitted by the human body and the environment, it can be calculated according to Wien's displacement law that the human wavelength range of the electromagnetic waves emitted by the human body at normal temperature is 9.322 to 9.358 μm. In order to ensure that the electromagnetic waves emitted by the human body and the environment can be received, the wavelength range of the electromagnetic waves received by the transceiver antenna can be set to a wavelength range that includes the human wavelength range, such as 2 to 22 μm, 4 to 14 μm, 9 to 10 μm, and 9.30 to 9.40 μm. The transceiver antenna converts the received electromagnetic waves into a target signal and outputs it to the processor 353. The transceiver antenna uses a highly conductive material, such as gold or copper.

[0049] Step S2, calling a preset algorithm according to the target signal to calculate the target wavelength range, and outputting a corresponding frequency coded signal to the coupled resonant circuit 352 according to the target wavelength range, wherein the frequency coded signal passes through the coupled resonant circuit 352 and then emits an infrared resonance wave in the target wavelength range through the inductive transceiver 351.

[0050] Specifically, the coupling resonance circuit 352 can adopt the coupling resonance circuit 352 in the prior art, and the preset algorithm is a pre-stored algorithm. After the processor 353 receives the target signal, it indicates that the therapeutic device is close to the human body, and then the preset algorithm is called to calculate the target wavelength range, that is, the wavelength range of the infrared resonance wave emitted by the transceiver antenna to the human body is determined to treat the human body. After determining the target wavelength range, the corresponding frequency coding signal is determined according to the target wavelength range, and the corresponding frequency coding signal is output to the coupling resonance circuit 352, so that the coupling resonance circuit 352 emits an infrared resonance wave in the target wavelength range through the induction transceiver antenna.

[0051] In this embodiment, the step of calculating the target wavelength range by calling a preset algorithm according to the target signal includes:

[0052] After receiving the target signal, the preset algorithm is called, wherein the preset algorithm includes: substituting a preset normal human body temperature range into Wien's displacement law to obtain a target wavelength range.

[0053] In practical applications, the normal human body temperature is 36.5-37.7°C, and Wien's displacement law is:

[0054] λmT=2897.7685μm·K,

[0055] Wherein, λm represents the target wavelength, T represents the temperature, and the normal human body temperature of 36.5°C is substituted into Wien's displacement law to obtain the following calculation:

[0056] λm=2897.7685 / (t+273.15)=2897.7685 / (36.5+273.15)=9.358μm,

[0057] Substituting the normal human body temperature of 37.7°C into Wien's displacement law, we can calculate:

[0058] λm=2897.7685 / (t+273.15)=2897.7685 / (37.7+273.15)=9.322μm, so the target wavelength range is 9.322μm-9.358μm. The infrared resonance wave within the target wavelength range is emitted to the human body, gradually affecting the microcirculation of the human body part used, polarizing the cells, and the polarized cells will rapidly promote human metabolism. Through the enhancement of human metabolic capacity, the circulation of functional tissues such as capillaries, microvessels, and lymphocytes is further realized.

[0059] In other embodiments, the step of invoking a preset algorithm according to the target signal to calculate the target wavelength range includes:

[0060] After receiving the target signal, calling the preset algorithm, wherein the preset algorithm includes:

[0061] After receiving the selected human body part instruction, determining the corresponding part temperature according to the human body part instruction;

[0062] Substituting the temperature of the part into Wien's displacement law to obtain the target wavelength;

[0063] The target wavelength is added to the preset wavelength to obtain the maximum wavelength, and the target wavelength is subtracted from the preset wavelength to obtain the minimum wavelength, thereby obtaining the target wavelength range.

[0064] In actual applications, different parts of the human body have slightly different temperatures, such as the wrist, acupoints, etc. The user can issue a body part command through an input device (such as a button, a touch screen, etc.). For example, if a wrist command is issued, the temperature of the part corresponding to the wrist command is 36.3°C. Then, 36.3°C is substituted into Wien's displacement law and the calculation is:

[0065] λm=2897.7685 / (t+273.15)=2897.7685 / (36.5+273.15)=9.364μm. Specifically, the preset wavelength range is 0.02μm~0.2μm, preferably 0.05μm. When the preset wavelength is 0.05μm, the maximum wavelength is 9.414μm, the minimum wavelength is 9.314μm, and the target wavelength range is 9.314μm~9.414μm. The target wavelength range is calculated according to the part temperature corresponding to the human body part instruction, and different infrared resonance waves can be emitted according to different parts of the human body, thereby achieving targeted treatment of different parts of the human body.

[0066] Further, outputting a corresponding frequency coded signal to the coupled resonance circuit 352 according to the target wavelength range includes:

[0067] Selecting a first frequency, a second frequency and a third frequency from the target wavelength range, wherein the electromagnetic wave corresponding to the first frequency is an electromagnetic wave that causes hyperpolarization of the cell membrane potential, the electromagnetic wave corresponding to the second frequency is an electromagnetic wave that causes depolarization of the cell membrane potential, and the electromagnetic wave corresponding to the third frequency is an electromagnetic wave that causes repolarization of the cell membrane potential;

[0068] The corresponding frequency coded signal is output to the coupling resonance circuit 352 according to a preset frequency sequence, wherein the preset frequency sequence is a preset transmission sequence of the first frequency, the second frequency and the third frequency.

[0069] In practical applications, such as Figure 3 As shown, the potential changes of cell membrane include: hyperpolarization, depolarization and repolarization. Figure 3The first point in the chart represents the resting membrane potential, the second point represents that the cell is stimulated and begins to depolarize, the third point represents that the cell membrane depolarization reaches the threshold potential level, the voltage-gated Na+ channel opens, and Na+ enters the cell, the fourth point represents that Na+ quickly enters the cell, causing the cell to depolarize, the fifth point represents that the Na+ channel closes and the K+ channel opens, the sixth point represents that K+ is transferred from the cell to the extracellular fluid to repolarize the cell, the seventh point represents the post-depolarization potential, at which point the Na+ channel is basically restored, the membrane potential is still lower than the resting membrane potential, and the gap with the threshold potential is small, so the excitability is higher than normal, the eighth point represents the post-hyperpolarization potential, at which point the K+ channel is still open, allowing more K+ to diffuse to Outside the membrane, hyperpolarization is caused. Point 9 indicates that the membrane potential of the cell returns to the resting membrane potential. Therefore, the frequency of the electromagnetic waves generated by the human body in the stage from point 2 to point 5 is used as the second frequency, the frequency of the electromagnetic waves generated by the human body in the stage from point 5 to point 7 is used as the third frequency, and the frequency of the electromagnetic waves generated by the human body in the stage from point 7 to point 8 is used as the first frequency. Then, frequency encoding information is output according to the pre-set emission sequence of the first frequency, the second frequency and the third frequency, so that the cell membrane potential produces hyperpolarization, depolarization and repolarization changes, thereby realizing active regulation of the cell membrane potential changes, allowing the sodium and potassium ions to move in an orderly manner, and effectively enhancing cell metabolism and activity.

[0070] In this embodiment, the preset frequency sequence is to cyclically emit electromagnetic waves in the order of the first frequency, the second frequency and the third frequency, that is, frequency encoding is performed in the order of the first frequency, the second frequency and the third frequency to obtain a corresponding frequency encoding signal, and the frequency encoding signal is sent to the coupling resonance circuit 352. The coupling resonance circuit 352 cyclically emits infrared resonance waves in the order of the first frequency, the second frequency and the third frequency through the transceiver antenna, so that the cell membrane potential changes cyclically according to the order of hyperpolarization, depolarization and repolarization.

[0071] In other embodiments, the preset frequency sequence is to cyclically emit electromagnetic waves in the order of the first frequency, the third frequency, and the second frequency, that is, frequency encoding is performed in the order of the first frequency, the third frequency, and the second frequency to obtain a corresponding frequency encoding signal, and the frequency encoding signal is sent to the coupling resonance circuit 352. The coupling resonance circuit 352 cyclically emits infrared resonance waves in the order of the first frequency, the third frequency, and the second frequency through the transceiver antenna, so that the cell membrane potential changes cyclically in the order of hyperpolarization, repolarization, and depolarization.

[0072] Furthermore, the infrared resonance wave is a forward and reverse direction wave, and the forward and reverse switching frequency of the forward and reverse direction wave is 30 to 300 MHz, and the forward and reverse switching frequency of the forward and reverse direction wave is preferably 100 to 200 MHz.

[0073] Furthermore, the inductive transceiver 351, the coupled resonant circuit 352 and the processor 353 form a resonant chip 35, such as Figure 4 As shown, the transcranial bionic far-infrared field effect therapeutic device also includes: a shell 31, a rotating mechanism and a driving mechanism. The driving mechanism is arranged in the shell 31, the output end of the driving mechanism is fixedly connected to the driving mechanism, and a plurality of resonance chips 35 are arranged in an array on the rotating mechanism.

[0074] Specifically, the shell 31 includes: an upper shell 311 and a lower shell 312. The upper shell 311 and the lower shell 312 are snap-connected, so that the shell 31 can be disassembled, which is convenient for inspection and replacement of components in the shell 31. A modification ring 313 is also provided on the upper shell 311 to cover the snap-connection between the upper shell 311 and the lower shell 312. When the therapeutic device is worn on the body, the driving mechanism drives the rotating mechanism to rotate, and the rotating mechanism drives the resonance chip 35 to rotate, so that multiple resonance chips 35 vibrate at high speed at the same time, and evenly emit infrared resonance waves to the wearing part of the human body, promote resonance with human tissue, so as to improve the therapeutic effect.

[0075] Furthermore, the driving mechanism includes a brushless motor 32, the rotating mechanism includes a rotating tray 33, the output end of the brushless motor 32 is fixedly connected to the rotating tray 33, and the resonance chip 35 is arranged on the rotating tray 33. Specifically, multiple resonance chips 35 can be first arranged on the rotating plate 34, and then the rotating plate 34 is arranged on the rotating tray 33. The voltage range of the brushless motor 32 is 7.0-12.0V, and the speed range of the brushless motor 32 rotating tray 33 is 2500-3000RPM, and further 2650-2850RPM.

[0076] Furthermore, a nano-light component 36 is provided in the housing 31 for emitting infrared light, wherein the wavelength of the infrared light is any one of 630nm to 650nm and 860nm to 900nm. By providing the nano-light component 36, the resonance infrared wave can be coordinated to treat the wearing part of the human body, further improving the treatment effect.

[0077] Furthermore, the nano-light component 36 includes: an annular plate 361 and multiple nano-lamp beads 362; the annular plate 361 is arranged in the shell 31, the resonance chip 35 is located in the inner circle of the annular plate 361, and the multiple nano-lamp beads 362 are evenly arranged on the annular plate 361, so that the infrared light emitted by the nano-light component 36 is more uniform.

[0078] Furthermore, the housing 31, the rotating mechanism and the driving mechanism form a treatment head 3, such as Figure 5As shown, the transcranial bionic far-infrared field effect therapeutic device also includes: a head-mounted body 1 and a plurality of clamping arms 2; the clamping arms 2 are arranged on the head-mounted body 1, and each of the clamping arms 2 is provided with the therapeutic head 3.

[0079] Through the arrangement of the head-mounted main body 1 and multiple clamping arms 2, the therapeutic device can be easily worn on the human head without the need to be held in hand, and is easy to use. In actual applications, the length and number of the clamping arms 2 can be adjusted, as well as the spacing between adjacent clamping arms 2, so that the therapeutic head 3 on the clamping arm 2 can correspond to the acupuncture points on the head, thereby facilitating treatment of the acupuncture points on the head.

[0080] Furthermore, if Figure 6 As shown, the clamping arm 2 includes: a connecting arm 21, a first cover body 22 and a second cover body 23; one end of the connecting arm 21 is arranged on the head-mounted body 1, and the other end of the connecting arm 21 is provided with a plurality of adjustment slots 211, and the first cover body 22 is provided with at least one adjustment block 221, and the adjustment block 221 is clamped in the adjustment slot 211, the second cover body 23 is fixedly connected to the first cover body 22 to clamp the connecting arm 21, and the treatment head 3 is fixedly connected to the first cover body 22.

[0081] In actual application, multiple adjustment slots 211 are arranged along the length direction of the connecting arm 21. Through the setting of the adjustment slots 211, it is possible to select a suitable adjustment slot 211 from all the adjustment slots 211 to be engaged with the adjustment block 221 according to the actual required length. For example, when the length of the clamping arm 2 needs to be longer, the lower adjustment slot 211 can be selected to be engaged with the adjustment block 221. When the length of the clamping arm 2 needs to be shorter, the upper adjustment slot 211 can be selected to be engaged with the adjustment block 221 to adjust the length of the clamping arm 2. The first cover body 22 and the second cover body 23 are fixedly connected by bolts, so that the first cover body 22 and the second cover body 23 are detachable, so that the first cover body 22 and the second cover body 23 can be disassembled and separated, and the adjustment slot 211 to be engaged with the adjustment block 221 can be adjusted to adjust the length of the clamping arm 2. In actual application, the number of clamping arms 2 and the spacing between adjacent clamping arms 2 can also be adjusted, so that the treatment head 3 on the clamping arm 2 can correspond to the acupuncture points on the skull, which is convenient for treatment of the acupuncture points on the skull.

[0082] Furthermore, if Figure 7 As shown, the head-mounted body 1 includes: a front shell 11 and a rear shell 12; the front shell 11 is provided with a plurality of first openings 111 corresponding one-to-one to the plurality of clamping arms 2, and the rear shell 12 is provided with a plurality of second openings corresponding one-to-one to the plurality of clamping arms 2, one end of the clamping arm 2 is fixedly connected to the inner wall of the front shell 11, and after the front shell 11 and the rear shell 12 are snapped together, the first opening 111 and the second opening form a through hole adapted to the clamping arm 2.

[0083] In this embodiment, the clamping arm 2 is first placed in the corresponding first opening 111, one end of the clamping arm 2 is fixed to the inner wall of the front shell 11 by a screw, and the other end of the clamping arm 2 is located outside the head-mounted body 1, and then the second opening is aligned with the corresponding clamping arm 2. Through the setting of the first opening 111 and the second opening, after the front shell 11 and the rear shell 12 are clamped, the first opening 111 and the second opening form a through hole adapted to the clamping arm 2, which can accommodate the clamping arm 2 and prevent the clamping arm 2 from affecting the clamping of the front shell 11 and the rear shell 12.

[0084] Furthermore, if Figure 7 As shown, it also includes: a silicone pad 13, a pressure ring 14 and a first fixing member; the first fixing member is not shown in the figure, one side of the silicone pad 13 abuts against the side of the headband main body 1 close to the human body, and the other side of the silicone pad 13 abuts against the pressure ring 14, and the pressure ring 14 is fixedly arranged on the side of the headband main body 1 close to the human body through the first fixing member to compress the silicone pad 13.

[0085] Specifically, in the present embodiment, the first fixing member may be a first screw, one side of the silicone pad 13 is in contact with the outer wall of the front shell 11, and the other side of the silicone pad 13 is circumferentially provided with a pressure groove matched with the pressure ring 14, and the pressure ring 14 is in contact with the bottom of the pressure groove, and the rod of the first screw passes through the pressure ring 14, the silicone pad 13 and the front shell 11 in sequence, and is threadedly connected to fix the silicone pad 13 on the front shell 11. Through the arrangement of the silicone pad 13, the wearer's comfort is improved after wearing the therapeutic device.

[0086] Furthermore, if Figure 6 As shown, it also includes: a silicone sleeve 4, a front clamping ring 5, a rear clamping ring 6 and a second fixing piece; the second fixing piece is not shown in the figure, the inner side of the silicone sleeve 4 abuts against the front clamping ring 5, and the other side of the silicone sleeve 4 abuts against the rear clamping ring 6, and the connecting part of the second fixing piece passes through the treatment head 3, the rear clamping ring 6 and the silicone sleeve 4 in sequence and is fixedly connected with the rear clamping ring 6.

[0087] Specifically, in this embodiment, the second fixing member can be a second screw, and the open end of the silicone sleeve 4 is bent inward with a flexible edge, the inner side of the flexible edge abuts against the front clamping ring 5, and the outer side of the flexible edge abuts against the rear clamping ring 6. The rod of the second screw (that is, the connecting part of the second fixing member) passes through the treatment head 3, the rear clamping ring 6 and the silicone sleeve 4 in sequence, and is threadedly connected with the rear clamping ring 6 to fix the silicone sleeve 4 on the treatment head 3. Through the provision of the silicone sleeve 4, the wearer's comfort is improved after wearing the therapeutic device.

[0088] Furthermore, it also includes: a battery 7; the battery 7 is arranged in the head-mounted body 1, and the battery 7 is electrically connected to the driving component 33. Specifically, the battery 7 can be a rechargeable battery, such as a lithium battery, which can realize power supply to the driving component 33 and also power supply to the far-infrared chip 31, so that the therapeutic device can be used in any place, reducing the dependence on a fixed power source.

[0089] Furthermore, a button 15 is provided on the head-mounted body 1, and a circuit board 14 is provided inside the head-mounted body 1; the button 15 and the battery 7 are both electrically connected to the circuit board 14. Specifically, the button 15 is provided on the rear shell 12, and the setting of the button 15 facilitates the control of the start and stop of the therapeutic device.

[0090] The transcranial bionic far-infrared field effect therapeutic device of this embodiment, after the processor 353 receives the target signal, calls the preset algorithm to calculate the target wavelength range, that is, determines the wavelength range of the infrared resonance wave emitted by the transceiver antenna to the human body to treat the human body. After determining the target wavelength range, the corresponding frequency coding signal is determined according to the target wavelength range, and the corresponding frequency coding signal is output to the coupling resonance circuit 352, so that the coupling resonance circuit 352 can emit infrared resonance waves in the target wavelength range through the induction transceiver antenna, and emit infrared resonance waves according to the frequency coding signal, thereby realizing active regulation of changes in cell membrane potential, allowing sodium and potassium ions to move in an orderly manner, and effectively enhancing cell metabolism and activity.

[0091] The present invention provides a bionic far-infrared field effect treatment method, including: applied to a transcranial bionic far-infrared field effect treatment device, the device includes an inductive transceiver 351, a coupled resonant circuit 352 and a processor 353 suitable for implementing a computer program; the method includes the following steps:

[0092] Receiving a target signal transmitted by the inductive transceiver 351 , wherein the target current is a target signal converted from a target electromagnetic wave received by the inductive transceiver 351 ;

[0093] The target wavelength range is calculated by calling a preset algorithm according to the target signal, and an oscillation signal of the target frequency is output to the coupling resonance circuit 352 according to the target wavelength range, wherein the oscillation signal emits an infrared resonance wave of the target wavelength range through the inductive transceiver 351 after passing through the coupling resonance circuit 352.

[0094] In one embodiment, the step of calculating the target wavelength range by calling a preset algorithm according to the target signal includes:

[0095] After receiving the target signal, calling the preset algorithm, wherein the preset algorithm includes:

[0096] Substitute the preset normal human body temperature into Wien's displacement law to obtain the target wavelength.

[0097] In one embodiment, the target wavelength range is 9.322 μm to 9.358 μm.

[0098] In one embodiment, the step of calculating the target wavelength range by calling a preset algorithm according to the target signal includes:

[0099] After receiving the target signal, calling the preset algorithm, wherein the preset algorithm includes:

[0100] After receiving the selected human body part instruction, determining the corresponding part temperature according to the human body part instruction;

[0101] Substituting the temperature of the part into Wien's displacement law to obtain the target wavelength;

[0102] The target wavelength is added to the preset wavelength to obtain the maximum wavelength, and the target wavelength is subtracted from the preset wavelength to obtain the minimum wavelength, thereby obtaining the target wavelength range.

[0103] In one embodiment, outputting a corresponding frequency coded signal to the coupled resonance circuit 352 according to the target wavelength range includes:

[0104] Selecting a first frequency, a second frequency and a third frequency from the target wavelength range, wherein the electromagnetic wave corresponding to the first frequency is an electromagnetic wave that causes hyperpolarization of the cell membrane potential, the electromagnetic wave corresponding to the second frequency is an electromagnetic wave that causes depolarization of the cell membrane potential, and the electromagnetic wave corresponding to the third frequency is an electromagnetic wave that causes repolarization of the cell membrane potential;

[0105] The corresponding frequency coded signal is output to the coupling resonance circuit 352 according to a preset frequency sequence, wherein the preset frequency sequence is a preset transmission sequence of the first frequency, the second frequency and the third frequency.

[0106] In one embodiment, the preset frequency sequence is to cyclically emit electromagnetic waves in the order of a first frequency, a second frequency and a third frequency.

[0107] In one embodiment, the preset frequency sequence is to cyclically emit electromagnetic waves in the order of a first frequency, a third frequency and a second frequency.

[0108] In one embodiment, a computer device is provided. The computer device may be a server, and its internal structure diagram may be as follows: Figure 8As shown. The computer device includes a processor, a memory, a network interface and a database connected through a system bus. Among them, the processor of the computer device is used to provide computing and control capabilities. The memory of the computer device includes a non-volatile storage medium and an internal memory. The non-volatile storage medium stores an operating system, a computer program and a database. The internal memory provides an environment for the operation of the operating system and the computer program in the non-volatile storage medium. The network interface of the computer device is used to communicate with an external terminal through a network connection.

[0109] Those skilled in the art will understand that Figure 8 The structure shown in the figure is only a block diagram of a part of the structure related to the solution of the present application, and does not constitute a limitation on the computer device to which the solution of the present application is applied. The specific computer device may include more or fewer components than those shown in the figure, or combine certain components, or have a different arrangement of components.

[0110] In one embodiment, a computer device is provided, including a memory and a processor, wherein the memory stores a computer program, and when the processor executes the computer program, the following steps are implemented:

[0111] Receiving a target signal transmitted by the inductive transceiver 351 , wherein the target current is a target signal converted from a target electromagnetic wave received by the inductive transceiver 351 ;

[0112] The target wavelength range is calculated by calling a preset algorithm according to the target signal, and an oscillation signal of the target frequency is output to the coupling resonance circuit 352 according to the target wavelength range, wherein the oscillation signal emits an infrared resonance wave of the target wavelength range through the inductive transceiver 351 after passing through the coupling resonance circuit 352.

[0113] In one embodiment, the step of calculating the target wavelength range by calling a preset algorithm according to the target signal includes:

[0114] After receiving the target signal, calling the preset algorithm, wherein the preset algorithm includes:

[0115] Substitute the preset normal human body temperature into Wien's displacement law to obtain the target wavelength.

[0116] In one embodiment, the target wavelength range is 9.322 μm to 9.358 μm.

[0117] In one embodiment, the step of calculating the target wavelength range by calling a preset algorithm according to the target signal includes:

[0118] After receiving the target signal, calling the preset algorithm, wherein the preset algorithm includes:

[0119] After receiving the selected human body part instruction, determining the corresponding part temperature according to the human body part instruction;

[0120] Substituting the temperature of the part into Wien's displacement law to obtain the target wavelength;

[0121] The target wavelength is added to the preset wavelength to obtain the maximum wavelength, and the target wavelength is subtracted from the preset wavelength to obtain the minimum wavelength, thereby obtaining the target wavelength range.

[0122] In one embodiment, outputting a corresponding frequency coded signal to the coupled resonance circuit 352 according to the target wavelength range includes:

[0123] Selecting a first frequency, a second frequency and a third frequency from the target wavelength range, wherein the electromagnetic wave corresponding to the first frequency is an electromagnetic wave that causes hyperpolarization of the cell membrane potential, the electromagnetic wave corresponding to the second frequency is an electromagnetic wave that causes depolarization of the cell membrane potential, and the electromagnetic wave corresponding to the third frequency is an electromagnetic wave that causes repolarization of the cell membrane potential;

[0124] The corresponding frequency coded signal is output to the coupling resonance circuit 352 according to a preset frequency sequence, wherein the preset frequency sequence is a preset transmission sequence of the first frequency, the second frequency and the third frequency.

[0125] In one embodiment, the preset frequency sequence is to cyclically emit electromagnetic waves in the order of a first frequency, a second frequency and a third frequency.

[0126] In one embodiment, the preset frequency sequence is to cyclically emit electromagnetic waves in the order of a first frequency, a third frequency and a second frequency.

[0127] In one embodiment, a computer readable storage medium is provided, on which a computer program is stored, and when the computer program is executed by a processor, the following steps are implemented:

[0128] Receiving a target signal transmitted by the inductive transceiver 351 , wherein the target current is a target signal converted from a target electromagnetic wave received by the inductive transceiver 351 ;

[0129] The target wavelength range is calculated by calling a preset algorithm according to the target signal, and an oscillation signal of the target frequency is output to the coupling resonance circuit 352 according to the target wavelength range, wherein the oscillation signal emits an infrared resonance wave of the target wavelength range through the inductive transceiver 351 after passing through the coupling resonance circuit 352.

[0130] In one embodiment, the step of calculating the target wavelength range by calling a preset algorithm according to the target signal includes:

[0131] After receiving the target signal, calling the preset algorithm, wherein the preset algorithm includes:

[0132] Substitute the preset normal human body temperature into Wien's displacement law to obtain the target wavelength.

[0133] In one embodiment, the target wavelength range is 9.322 μm to 9.358 μm.

[0134] In one embodiment, the step of calculating the target wavelength range by calling a preset algorithm according to the target signal includes:

[0135] After receiving the target signal, calling the preset algorithm, wherein the preset algorithm includes:

[0136] After receiving the selected human body part instruction, determining the corresponding part temperature according to the human body part instruction;

[0137] Substituting the temperature of the part into Wien's displacement law to obtain the target wavelength;

[0138] The target wavelength is added to the preset wavelength to obtain the maximum wavelength, and the target wavelength is subtracted from the preset wavelength to obtain the minimum wavelength, thereby obtaining the target wavelength range.

[0139] In one embodiment, outputting a corresponding frequency coded signal to the coupled resonance circuit 352 according to the target wavelength range includes:

[0140] Selecting a first frequency, a second frequency and a third frequency from the target wavelength range, wherein the electromagnetic wave corresponding to the first frequency is an electromagnetic wave that causes hyperpolarization of the cell membrane potential, the electromagnetic wave corresponding to the second frequency is an electromagnetic wave that causes depolarization of the cell membrane potential, and the electromagnetic wave corresponding to the third frequency is an electromagnetic wave that causes repolarization of the cell membrane potential;

[0141] The corresponding frequency coded signal is output to the coupling resonance circuit 352 according to a preset frequency sequence, wherein the preset frequency sequence is a preset transmission sequence of the first frequency, the second frequency and the third frequency.

[0142] In one embodiment, the preset frequency sequence is to cyclically emit electromagnetic waves in the order of a first frequency, a second frequency and a third frequency.

[0143] In one embodiment, the preset frequency sequence is to cyclically emit electromagnetic waves in the order of a first frequency, a third frequency and a second frequency.

[0144] Those skilled in the art can understand that all or part of the processes in the above-mentioned embodiment methods can be completed by instructing the relevant hardware through a computer program, and the computer program can be stored in a non-volatile computer-readable storage medium. When the computer program is executed, it can include the processes of the embodiments of the above-mentioned methods. Among them, any reference to memory, storage, database or other media used in the embodiments provided in this application can include non-volatile and / or volatile memory. Non-volatile memory can include read-only memory (ROM), programmable ROM (PROM), electrically programmable ROM (EPROM), electrically erasable programmable ROM (EEPROM) or flash memory. Volatile memory can include random access memory (RAM) or external cache memory. As an illustration and not limitation, RAM is available in many forms, such as static RAM (SRAM), dynamic RAM (DRAM), synchronous DRAM (SDRAM), double data rate SDRAM (DDRSDRAM), enhanced SDRAM (ESDRAM), synchronous link (Synchlink) DRAM (SLDRAM), memory bus (Rambus) direct RAM (RDRAM), direct memory bus dynamic RAM (DRDRAM), and memory bus dynamic RAM (RDRAM).

[0145] The technical features of the above embodiments may be combined arbitrarily. To make the description concise, not all possible combinations of the technical features in the above embodiments are described. However, as long as there is no contradiction in the combination of these technical features, they should be considered to be within the scope of this specification.

Claims

1. Transcranial bionic far-infrared field effect therapeutic device, characterized in that: include: An inductive transceiver, a coupled resonant circuit and a processor suitable for implementing a computer program; The inductive transceiver is connected to the processor, the processor is connected to the coupling resonant circuit, and the coupling resonant circuit is connected to the inductive transceiver; The computer program is loaded by the processor and executes the following steps: Receiving a target signal transmitted by the inductive transceiver, wherein the target signal is a target signal converted from a target electromagnetic wave received by the inductive transceiver; A preset algorithm is called according to the target signal to calculate a target wavelength range, and a corresponding frequency coded signal is output to the coupled resonant circuit according to the target wavelength range, wherein the frequency coded signal, after passing through the coupled resonant circuit, emits an infrared resonance wave in the target wavelength range through an inductive transceiver; Outputting a corresponding frequency coded signal to the coupled resonant circuit according to the target wavelength range includes: Selecting a first frequency, a second frequency and a third frequency from the target wavelength range, wherein the electromagnetic wave corresponding to the first frequency is an electromagnetic wave that causes hyperpolarization of the cell membrane potential, the electromagnetic wave corresponding to the second frequency is an electromagnetic wave that causes depolarization of the cell membrane potential, and the electromagnetic wave corresponding to the third frequency is an electromagnetic wave that causes repolarization of the cell membrane potential; Outputting corresponding frequency coded signals to the coupled resonant circuit according to a preset frequency sequence, wherein: The preset frequency sequence is to cyclically transmit electromagnetic waves in the order of the first frequency, the second frequency and the third frequency, or the preset frequency sequence is to cyclically transmit electromagnetic waves in the order of the first frequency, the third frequency and the second frequency; The infrared resonance wave is a forward and reverse direction wave, and the forward and reverse switching frequency of the forward and reverse direction wave is 100-200MHz; The step of calculating the target wavelength range by calling a preset algorithm according to the target signal includes: After receiving the target signal, calling the preset algorithm, wherein the preset algorithm includes: Substitute the preset normal human body temperature into Wien's displacement law to obtain the target wavelength; The target wavelength range is 9.322 μm to 9.358 μm.

2. The transcranial bionic far-infrared field effect therapeutic device according to claim 1, characterized in that: The step of calculating the target wavelength range by calling a preset algorithm according to the target signal includes: After receiving the target signal, calling the preset algorithm, wherein the preset algorithm includes: After receiving the selected human body part instruction, determining the corresponding part temperature according to the human body part instruction; Substituting the temperature of the part into Wien's displacement law to obtain the target wavelength; The target wavelength is added to the preset wavelength to obtain the maximum wavelength, and the target wavelength is subtracted from the preset wavelength to obtain the minimum wavelength, thereby obtaining the target wavelength range.

Images